Ever since the first photocoagulation with sunlight was tested from the rooftop of a Hamburg eye clinic in 1949, dedicated
ZEISS employees have sought intense dialogue with visionary ophthalmologists of their time. Dialogue that led, in 1957, to the first commercially available photocoagulator in the world.
Simultaneously this marked the birth of contactless surgery on the human eye.
ZEISS has been a strong driving force behind the focused optical therapy of retinal diseases. Committed to this tradition, the VISULAS 532s from ZEISS ranks seamlessly into a chain of
innovative solutions with one sole objective: precise, effective and gentle therapy to preserve the eyesight and quality of life of patients.
Exceptionally precise beam control and treatment accuracy.
Extremely compact and reliable in daily clinical practice.
Outstandingly ergonomic and intuitive to operate. The VISULAS® 532s from ZEISS is an impressive, powerful, diode-pumped solid-state laser for controlled and gentle photocoagulation of the retina
The VISULAS 532s is setting performance benchmarks. The efficient solid-state laser
reveals its sustainable strength even in high-demand practices.